Philips to Introduce AI-Powered, Helium-Free MRI System at RSNA
Offering a variety of AI-enabled tools to facilitate radiology workflow efficiency, the BlueSeal MRI system is reportedly the first wide bore, helium-free 1.5T MRI platform in the field.
Combining artificial intelligence (AI) enhancements for workflow efficiency with a lightweight design and helium-free operation, Philips will unveil the next-generation BlueSeal MRI system at the upcoming 2024 Radiological Society of North America (RSNA) annual meeting in Chicago.
Emphasizing an eco-friendly design, the BlueSeal 1.5T 70 cm MRI system is up to 1,700 kg lighter than comparable systems and the system’s lack of a need for a vent pipe provides additional flexibility with installation, according to Philips.
The next-generation, helium-free BlueSeal 1.5T MRI system will be introduced by Philips at the upcoming 2024 Radiological Society of North America (RSNA) annual meeting in Chicago. (Image courtesy of Philips.)
Philips emphasized that the BlueSeal MRI system also offers a variety of AI-enabled features including:
• automated planning, scanning and image processing for up to 80 percent of MRI procedures with the SmartExam feature;
• a SmartSpeed feature that enables up to 65 percent higher image resolution without additional scan time; and
• integrated imaging and reading with the cloud-based SmartReading technology, which also facilitates enhanced precision diagnosis of neurological conditions and prostate cancer through partnerships with icometrix and Quibim.
“With AI applications seamlessly integrated into our latest 1.5T BlueSeal scanner, we have now applied AI to every aspect of the MRI workflow – from patient setup and high-resolution image capture to quantitative data extraction, advanced diagnostics, and reporting. With this latest innovation, we continue our commitment to deliver wider access to quality MRI to more patients across multiple settings,” noted Ioannis Panagiotelis, Ph.D., the global business leader of MRI at Philips.
FDA Clears Enhanced MRI-Guided Laser Ablation System
June 5th 2025An alternative to an open neurosurgical approach, the Visualase V2 MRI-Guided Laser Ablation System reportedly utilizes laser interstitial thermal therapy (LITT) for targeted soft tissue ablation in patients with brain tumors and focal epilepsy.
Can Abbreviated MRI Have an Impact in Differentiating Intraductal Papilloma and Ductal Secretion?
June 3rd 2025For patients with inconclusive ultrasound results, abbreviated breast MRI offers comparable detection of intraductal papilloma as a full breast MRI protocol at significantly reduced times for scan acquisition and interpretation, according to a new study.
FDA Issues Expanded Pediatric Approval of MRI Contrast Agent for Lung Ventilation Assessment
June 2nd 2025Previously approved for MRI lung ventilation evaluation in adults and children 12 and older, the hyperpolarized contrast agent Xenoview can now be utilized for pediatric patients six years and older.
